Gender Differences in the Treatment of Ischemic Heart Disease

Title: Gender Differences in the Treatment of Ischemic Heart Disease

Volume: 17 Issue: 11

Author(s): Marcin Barylski, Dimitri P. Mikhailidis, Maciej Ciebiada, Jacek Rysz and Maciej Banach

Affiliation:

Keywords: Ischemic heart disease, gender difference, risk factor, treatment, cardiomyopathy, calcification, placental, Asymptomatic, atheroma, vasculitides, menopause, catecholamine, electrocardiogram, echocardiography, radioisotope, Tomography, luminal, plasminogen

Abstract: Ischemic heart disease (IHD) is a leading cause of mortality and morbidity in most developed countries. Many studies revealed gender differences in the presentation, prevalence, and clinical outcomes of IHD. Compared with females, ST-segment elevation myocardial infarction is more often diagnosed in men. They also have a higher prevalence of IHD. These findings indicate that gender may have an important influence on IHD. Appropriate prevention, rapid diagnosis, and optimal treatment may essentially improve the care of all patients. It is therefore necessary to take into account gender differences in the features of IHD between males and females.

Cite this article as:

Barylski Marcin, P. Mikhailidis Dimitri, Ciebiada Maciej, Rysz Jacek and Banach Maciej, Gender Differences in the Treatment of Ischemic Heart Disease, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656936